Position in IDXX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$3,350,790
-$50,330 QoQ
Shares Held
6,365
+5.2% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#418
of 1,288 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IDXX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026PROFUND ADVISORS LLC holds $15,038,497 across 17 Diagnostics & Research names. IDXX ranks #1 (22.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
This page
|
6,365 | $3,350,790 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
4,138 | $2,074,627 | |
| 3 | NTRA |
Natera, Inc.
|
6,205 | $1,684,347 | |
| 4 | VCYT |
Veracyte, Inc.
|
24,694 | $1,450,278 | |
| 5 | GRAL |
GRAIL, Inc.
|
20,078 | $1,370,725 | |
| 6 | DHR |
Danaher Corp /De/
|
7,015 | $1,336,217 | |
| 7 | ILMN |
Illumina, Inc.
|
3,154 | $554,567 | |
| 8 | CDNA |
CareDx, Inc.
|
16,518 | $470,763 |
All Filings in IDXX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,350,790 | 6,365 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $3,401,120 | 6,053 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $5,197,779 | 7,683 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $4,354,674 | 6,816 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $3,758,670 | 7,008 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $2,688,939 | 6,403 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $3,016,458 | 7,296 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,440,042 | 6,809 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,536,097 | 7,258 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $3,992,782 | 7,395 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $4,308,853 | 7,763 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,857,559 | 6,535 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,501,105 | 4,980 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $2,353,376 | 4,706 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,025,521 | 4,965 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $1,678,195 | 5,151 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $1,947,603 | 5,553 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $3,663,113 | 6,696 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $5,961,038 | 9,053 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $5,816,630 | 9,353 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $5,469,223 | 8,660 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $4,335,775 | 8,861 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $3,598,564 | 7,199 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $2,729,362 | 6,943 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,382,104 | 7,215 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $1,595,150 | 6,585 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||